Dupilumab improves pediatric type 2 asthma outcomes independent of patient baseline characteristics.

Maspero, Jorge F; Fiocchi, Alessandro G; Deschildre, Antoine; Bacharier, Leonard B; Altincatal, Arman; Laws, Elizabeth; Lederer, David J; Akinlade, Bolanle; Hardin, Megan

Maspero, Jorge F; Fiocchi, Alessandro G; Deschildre, Antoine; Bacharier, Leonard B; Altincatal, Arman; Laws, Elizabeth; Lederer, David J; Akinlade, Bolanle; Hardin, Megan.

Afiliação

Maspero JF; Fundación CIDEA, Buenos Aires, Argentina. Electronic address: jorge.maspero@fundacioncidea.org.ar.
Fiocchi AG; Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Deschildre A; Pediatric Pulmonology and Allergy Department, CHU Lille, Hôpital Jeanne de Flandre, Université de Lille, Lille, France.
Bacharier LB; Division of Allergy, Immunology and Pulmonary Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn.
Altincatal A; Sanofi, Cambridge, Mass.
Laws E; Sanofi, Bridgewater, NJ.
Lederer DJ; Regeneron Pharmaceuticals Inc., Tarrytown, New York, NY.
Akinlade B; Regeneron Pharmaceuticals Inc., Tarrytown, New York, NY.
Hardin M; Sanofi, Cambridge, Mass.

J Allergy Clin Immunol Pract ; 2024 Aug 08.

Article em En | MEDLINE | ID: mdl-39127101

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2024 Tipo de documento: Article